News and Press Releases
Press releases
Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
Toronto, Ontario – January 20, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical ...
0Theralase Launches First Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
Toronto, Ontario – January 19, 2021, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
0Theralase Announces Warrant Extension
Toronto, Ontario – January 8, 2021, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmace...
0University of British Columbia Launched as Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Toronto, Ontario – December 7, 2020, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
0Theralase Release 3Q2020 Financial Statements
Toronto, Ontario – November 27, 2020, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase Granted FDA Fast Track Designation for NMIBC Phase II Clinical Study
Toronto, Ontario –November 23, 2020, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical...
0Theralase Technology Demonstrates High Kill Rate of Coronavirus (BSL-2)
Toronto, Ontario – November 13, 2020, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase Releases Quarterly Newsletter
Toronto, Ontario – October 26, 2020, Theralase® Technologies Inc. (“Theralase” or the “Company“)(TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharm...
0Theralase Announces Warrant Extension
Toronto, Ontario – September 30, 2020, Theralase® Technologies Inc. (“Theralase” or “Company“) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmac...
0Theralase Provides Update on Bladder Cancer Study
Toronto, Ontario – September 24, 2020, Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical st...
0in the news
BTv – Theralase® an innovative medical technology for bladder cancer treatment – 2018
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.
